Clinical Trials Browser

Phase 2 × entecavir × Lymphoid × Clear all

NCT01914744 2013-08-02

Entecavir Versus Lamivudine for Preventing the Risk of Hepatitis B Reactivation in NHL

Phase 2 Unknown

Lymphoma, Non-Hodgkin